Assenagon Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$922K Buy
63,016
+16,430
+35% +$244K ﹤0.01% 981
2026
Q1
$675K Buy
46,586
+33,951
+269% +$394K ﹤0.01% 960
2025
Q4
$121K Sell
12,635
-33,208
-72% -$318K ﹤0.01% 1129
2025
Q3
$431K Buy
+45,843
New +$438K ﹤0.01% 1075
2024
Q4
Sell
-50,745
Closed -$1.25M 1324
2024
Q3
$1.25M Buy
50,745
+3,733
+8% +$96.8K ﹤0.01% 1085
2024
Q2
$1.19M Hold
47,012
﹤0.01% 1052
2024
Q1
$1.19M Sell
47,012
-12
-0% -$290 ﹤0.01% 1015
2023
Q4
$1.07M Hold
47,024
﹤0.01% 1078
2023
Q3
$876K Hold
47,024
﹤0.01% 1074
2023
Q2
$1.22M Hold
47,024
﹤0.01% 916
2023
Q1
$1.35M Sell
47,024
-672
-1% -$20K 0.01% 960
2022
Q4
$1.41M Sell
47,696
-42,357
-47% -$1.2M 0.01% 942
2022
Q3
$2.14M Hold
90,053
0.01% 687
2022
Q2
$2.01M Sell
90,053
-1,872
-2% -$41.8K 0.01% 832
2022
Q1
$2.31M Sell
91,925
-37,578
-29% -$1.15M 0.01% 785
2021
Q4
$4.64M Sell
129,503
-140,618
-52% -$5.63M 0.02% 535
2021
Q3
$11.5M Buy
270,121
+89,100
+49% +$3.67M 0.05% 272
2021
Q2
$7.84M Buy
181,021
+133,397
+280% +$5.68M 0.03% 387
2021
Q1
$1.94M Buy
47,624
+6,336
+15% +$240K 0.01% 715
2020
Q4
$1.87M Sell
41,288
-27,712
-40% -$1.05M 0.01% 539
2020
Q3
$2.44M Buy
+69,000
New +$2.49M 0.02% 546
2020
Q2
Sell
-98,670
Closed -$2.85M 1109
2020
Q1
$2.85M Buy
98,670
+83,948
+570% +$3.4M 0.03% 293
2019
Q4
$763K Buy
+14,722
New +$855K 0.01% 609
2019
Q3
Sell
-12,273
Closed -$499K 831
2019
Q2
$499K Sell
12,273
-6,578
-35% -$240K 0.01% 851
2019
Q1
$570K Sell
18,851
-37,379
-66% -$1.28M 0.01% 792
2018
Q4
$1.89M Buy
+56,230
New +$2.03M 0.03% 464

Other funds holding ANIK